Healthcare of Ontario Pension Plan Trust Fund Has $147,000 Holdings in Sotera Health (NYSE:SHC)

Posted by on Mar 4th, 2023

Healthcare of Ontario Pension Plan Trust Fund lowered its stake in Sotera Health (NYSE:SHC – Get Rating) by 30.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 21,566 shares of the company’s stock after selling 9,555 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Sotera Health were worth $147,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Fox Run Management L.L.C. acquired a new stake in shares of Sotera Health in the third quarter worth about $75,000. Cipher Capital LP acquired a new position in shares of Sotera Health during the 3rd quarter worth about $77,000. MetLife Investment Management LLC acquired a new position in shares of Sotera Health during the 1st quarter worth about $139,000. Federated Hermes Inc. acquired a new position in shares of Sotera Health during the 1st quarter worth about $157,000. Finally, Barclays PLC lifted its position in shares of Sotera Health by 50.5% during the 3rd quarter. Barclays PLC now owns 23,171 shares of the company’s stock worth $158,000 after purchasing an additional 7,773 shares during the last quarter. Institutional investors and hedge funds own 87.21% of the company’s stock.

Sotera Health Trading Up 2.5 %

SHC stock opened at $17.84 on Friday. The company has a current ratio of 0.81, a quick ratio of 2.74 and a debt-to-equity ratio of 5.15. The firm has a market cap of $5.04 billion, a P/E ratio of -21.49 and a beta of 2.09. Sotera Health has a 1-year low of $5.78 and a 1-year high of $24.90. The business’s 50 day moving average is $15.41 and its 200-day moving average is $11.86.

Analysts Set New Price Targets

SHC has been the subject of several research analyst reports. The Goldman Sachs Group cut their price objective on Sotera Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Wednesday, November 23rd. JPMorgan Chase & Co. raised Sotera Health from an “underweight” rating to a “neutral” rating and boosted their price objective for the stock from $6.00 to $18.00 in a research report on Monday, January 23rd. Royal Bank of Canada boosted their price target on Sotera Health from $8.00 to $19.00 and gave the company an “outperform” rating in a research note on Wednesday. Barclays upgraded Sotera Health from an “underweight” rating to an “overweight” rating and boosted their price target for the company from $6.00 to $22.00 in a research note on Tuesday, January 10th. Finally, Wolfe Research upgraded Sotera Health from a “peer perform” rating to an “outperform” rating and set a $25.00 price target on the stock in a research note on Tuesday, January 10th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Sotera Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.83.

Sotera Health Company Profile

(Get Rating)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.

Featured Stories

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health (NYSE:SHC – Get Rating).

Institutional Ownership by Quarter for Sotera Health (NYSE:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.